泰格医药(03347)附属拟2347.71万元购买日本MICRON 56.37%股权

智通财经2025-07-28

智通财经APP讯，泰格医药(03347)发布公告，公司全资附属公司株式会社泰格医药日本(日本泰格)与日本MICRON╱株式会社マイクロン(MICRON)原股东签署《股份转让协议》购买其持有的部分MICRON股权，本次转让完成后，日本泰格将持有MICRON 56.37%股权。购买价格为4.84亿日元，折合人民币约2347.71万元。据悉，MICRON成立于2005年，总部位于日本东京，员工人数超过...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2554774269?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-28 21:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2554774269","market":"sh","top_or_hot":-1,"title":"泰格医药(03347)附属拟2347.71万元购买日本MICRON 56.37%股权","media":"智通财经","content":"<div>\n<p>智通财经APP讯，泰格医药(03347)发布公告，公司全资附属公司株式会社泰格医药日本(日本泰格)与日本MICRON╱株式会社マイクロン(MICRON)原股东签署《股份转让协议》购买其持有的部分MICRON股权，本次转让完成后，日本泰格将持有MICRON 56.37%股权。购买价格为4.84亿日元，折合人民币约2347.71万元。据悉，MICRON成立于2005年，总部位于日本东京，员工人数超过...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1322802.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>泰格医药(03347)附属拟2347.71万元购买日本MICRON 56.37%股权</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n泰格医药(03347)附属拟2347.71万元购买日本MICRON 56.37%股权\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-28 21:05 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1322802.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，泰格医药(03347)发布公告，公司全资附属公司株式会社泰格医药日本(日本泰格)与日本MICRON╱株式会社マイクロン(MICRON)原股东签署《股份转让协议》购买其持有的部分MICRON股权，本次转让完成后，日本泰格将持有MICRON 56.37%股权。购买价格为4.84亿日元，折合人民币约2347.71万元。据悉，MICRON成立于2005年，总部位于日本东京，员工人数超过...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1322802.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0056508442.USD","symbol_name":"贝莱德世界科技基金A2","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1322802.html","article_id":"2554774269","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2554774269","pubTimestamp":1753707943,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，泰格医药 发布公告，公司全资附属公司株式会社泰格医药日本与日本MICRON╱株式会社マイクロン原股东签署《股份转让协议》购买其持有的部分MICRON股权，本次转让完成后，日本泰格将持有MICRON 56.37%股权。购买价格为4.84亿日元，折合人民币约2347.71万元。据悉，MICRON成立于2005年，总部位于日本东京，员工人数超过160人，是一家专注于医学影像及临床试验服务的CRO公司。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300347":"泰格医药","LU0056508442.USD":"贝莱德世界科技基金A2","BK1583":"高瓴概念","BK4575":"芯片概念","BK0216":"研究试验","BK4566":"资本集团","LU1316542783.SGD":"Janus Henderson Horizon Global Technology Leaders A2 SGD","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU1852331112.SGD":"Blackrock World Technology Fund A2 SGD-H","LU1146622755.USD":"安本中国A股股票基金A Acc","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU2250418816.HKD":"BGF WORLD TECHNOLOGY \"A\" (HKD) ACC","BK4579":"人工智能","LU0642271901.SGD":"Janus Henderson Horizon Global Technology Leaders A2 SGD-H","LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","BK4588":"碎股","LU2286300806.USD":"Allianz Cyber Security AT Acc USD","BK4605":"半导体精选","LU0127658192.USD":"EASTSPRING INVESTMENTS GLOBAL TECHNOLOGY \"A\" (USD) ACC","LU2089985449.USD":"MANULIFE GF GLOBAL SEMICONDUCTOR OPPORTUNITIES \"AA\" (USD) ACC","BK0077":"质押式回购","LU0274383776.USD":"MANULIFE GF US SMALL CAP EQUITY \"AA\" (USD) INC","LU1366333091.USD":"FIDELITY GLOBAL FOCUS \"A\" (USD) ACC","LU2360106780.USD":"BGF WORLD TECHNOLOGY \"A4\" (USD) INC","LU2048586759.USD":"ALLIANZ SMART ENERGY \"AT\" (USD) ACC","LU1820825898.SGD":"Aberdeen Standard SICAV I - China A Share Equity A Acc SGD-H","BK1141":"生命科学工具和服务","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","BK0028":"国家队","LU0719512351.SGD":"JPMorgan Funds - US Technology A (acc) SGD","BK1576":"医药外包概念","03347":"泰格医药","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","LU0157215616.USD":"FIDELITY GLOBAL FOCUS \"A\" INC","LU0081259029.USD":"UBS (LUX) EQUITY FUND - TECH OPPORTUNITY \"P\" (USD) ACC","BK4512":"苹果概念","BK4543":"AI","BK4527":"明星科技股","BK4553":"喜马拉雅资本持仓","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","BK4141":"半导体产品","BK4585":"ETF&股票定投概念","BK0174":"增持","LU0082616367.USD":"摩根大通美国科技A（dist）","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","BK4533":"AQR资本管理(全球第二大对冲基金)"},"translate_title":"A subsidiary of Tigermed (03347) plans to purchase 56.37% equity of Japan's MICRON for 23.4771 million yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300347":1,"03347":1},"content_text":"智通财经APP讯，泰格医药(03347)发布公告，公司全资附属公司株式会社泰格医药日本(日本泰格)与日本MICRON╱株式会社マイクロン(MICRON)原股东签署《股份转让协议》购买其持有的部分MICRON股权，本次转让完成后，日本泰格将持有MICRON 56.37%股权。购买价格为4.84亿日元，折合人民币约2347.71万元。据悉，MICRON成立于2005年，总部位于日本东京，员工人数超过160人，是一家专注于医学影像及临床试验服务的CRO公司。作为日本首家专注影像分析的CRO，MICRON以其卓越的技术能力及在影像生物标志物、AI影像支持等方面的独特实践，在日本临床研究领域树立了良好口碑，赢得了客户的长期信赖和赞誉，并在2024年入围全日本最佳合同研究组织奖。凭借其在临床研究领域的丰富经验和亚洲规模最大的影像专业团队之一，在近20年的发展过程中为超过250个客户提供相关服务，并助力超过40款产品成功上市。MICRON核心业务为影像分析业务，其主要客户为日本本土以及国外医药企业;另有部分其他相关业务，如临床监查业务，临床试验PM相关服务，提供医疗影像诊断软件(SaMD)的全生命周期服务应用，器械销售等业务。本次交易完成后，借助MICRON在日本市场的深厚根基与客户资源，有利于公司进一步深度拓展在日本及亚太的业务布局;同时，双方可以实现技术与人才深度融合，增强在医学影像和临床服务领域的综合竞争力，对公司未来经营产生积极影响，符合公司全体股东的利益。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2554774269","isCrawlerRequest":true}